"Super-Spreaders" and Person-to-Person Transmission of Andes Virus in Argentina.

@article{Martnez2020SuperSpreadersAP,
  title={"Super-Spreaders" and Person-to-Person Transmission of Andes Virus in Argentina.},
  author={Valeria Paula Mart{\'i}nez and Nicholas Di Paola and Daniel Oscar Alonso and Unai P{\'e}rez-Sautu and Carla M Bellomo and Ayel{\'e}n Alumin{\'e} Iglesias and Roc{\'i}o Coelho and Beatriz L{\'o}pez and Natalia Periolo and Peter A Larson and Elyse R. Nagle and Joseph A Chitty and Catherine B Pratt and Jorge D{\'i}az and Daniel Marcelo Cisterna and Josefina Campos and Heema Sharma and Bonnie Dighero-kemp and Emiliano Biondo and Lorena Cecilia Lewis and Constanza Rosario Anselmo and Camila Olivera and Fernanda Pontoriero and Enzo Lavarra and Jens H. Kuhn and Teresa Strella and Alexis Edelstein and Miriam I Burgos and Mario Kaler and Adolfo Luis Rubinstein and Jeffrey R. Kugelman and Mariano Sanchez-Lockhart and Claudia Perandones and Gustavo F. Palacios},
  journal={The New England journal of medicine},
  year={2020},
  volume={383 23},
  pages={
          2230-2241
        }
}
BACKGROUND From November 2018 through February 2019, person-to-person transmission of Andes virus (ANDV) hantavirus pulmonary syndrome occurred in Chubut Province, Argentina, and resulted in 34 confirmed infections and 11 deaths. Understanding the genomic, epidemiologic, and clinical characteristics of person-to-person transmission of ANDV is crucial to designing effective interventions. METHODS Clinical and epidemiologic information was obtained by means of patient report and from public… 

Evidence for Human-to-Human Transmission of Hantavirus: A Systematic Review

The balance of the evidence does not support the claim of human-to-human transmission of hantavirus strain Andes virus, and well-designed cohort and case-control studies that control for co-exposure to rodents are needed to inform public health recommendations.

Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies

Determining the antigenic sites for neutralizing antibodies will contribute to further therapeutic development for hantavirus-related diseases and inform the design of new broadly protective hantvirus vaccines.

Case Report: Hantavirus Cardiopulmonary Syndrome Diagnostic in the Face of the COVID-19 Pandemic

A fatal case of HCPS is described in a 24-year-old man who was hospitalized with fever, hemoconcentration, thrombocytopenia, leukocytosis, dry cough and a bilateral diffuse alveolar pulmonary infiltrate during the emergence of the COVID-19 pandemic in Brazil.

The kidney in hantavirus infection—epidemiology, virology, pathophysiology, clinical presentation, diagnosis and management

Novel insights into organ tropism, hantavirus-associated pathophysiology and overlapping clinical features, HFRS and HCPS are believed to be interconnected syndromes frequently involving the kidneys.

Emerging Hantaviruses in Central Argentina: first case of Hantavirus Pulmonary Syndrome caused by Alto Paraguay Virus and a novel orthohantavirus in Scapteromys aquaticus rodent

The first HPS case infected with Alto Paraguay virus reported in Argentina is presented, implicate an epidemiological warning regarding these new orthohantaviruses circulating in Central Argentina as well as new rodent species that must be considered as hosts from now on.

The Input of Structural Vaccinology in the Search for Vaccines against Bunyaviruses

The contribution of structural vaccinology and the current challenges that remain in the search for an efficient vaccine against some of the deadliest bunyaviruses are discussed.

Hantavirus Replication Cycle—An Updated Structural Virology Perspective

An update on the hantavirus replication cycle is provided with a special focus on structural virology aspects and many details of the viral amplification cycle are still unknown.

Common Themes in Zoonotic Spillover and Disease Emergence: Lessons Learned from Bat- and Rodent-Borne RNA Viruses

This review focuses on three questions regarding zoonotic viruses that originate in bats and rodents and what biological strategies have evolved that allow RNA viruses to reside inbats and rodents.

Cells of the human respiratory tract support the replication of pathogenic Old World orthohantavirus Puumala

The human respiratory epithelium is among the first targets of orthohantaviral infection and may contribute to virus replication, dissemination and pathogenesis of HFRS-causing orthohanaviruses.